Study | AUC | 95Â % CI | Cutoff value | Sensitivity (%) | Specificity (%) | Number of patients | |||
---|---|---|---|---|---|---|---|---|---|
TP rate | FP rate | FN rate | TN rate | ||||||
Aydogdu et al. [21] | 0.80 | NR | 29.5Â ng/ml | 0.88 | 0.73 | 55 | 18 | 8 | 48 |
Camou et al. [31] | 0.90 | NR | 150Â ng/ml | 0.93 | 0.44 | 40 | 4 | 3 | 3 |
de Geus et al. [34] | 0.80 | 0.69–0.88 | 304 ng/ml | 0.8 | 0.80 | 40 | 5 | 10 | 20 |
Fan et al. [30] | 0.86 | 0.81-0.93 | NR | 0.89 | 0.74 | 52 | 18 | 6 | 50 |
Hjortrup et al. [29] (p) | 0.66 | 0.54–0.77 | NR | 0.58 | 0.76 | 18 | 22 | 13 | 71 |
Hjortrup et al. [29] (u) | 0.71 | 0.59–0.82 | NR | 0.56 | 0.72 | 14 | 21 | 11 | 54 |
Li and Xu [22] | 0.94 | 0.68-0.97 | 50 μg/l | 0.94 | 0.88 | 16 | 7 | 1 | 50 |
Martensson et al. [33] (p) | 0.85 | 0.39-0.94 | >120Â ng/ml | 0.83 | 0.86 | 15 | 4 | 3 | 23 |
Martensson et al. [33] (u) | 0.86 | 0.68-1.00 | >68Â ng/mg.scr | 0.71 | 1.00 | 13 | 0 | 5 | 27 |
Niu et al. [23] | 0.91 | NR | 52 μg/g · scr | 0.88 | 0.87 | 23 | 5 | 3 | 29 |
Shapiro et al. [24] | 0.82 | 0.76-0.88 | NR | 0.96 | 0.51 | 23 | 312 | 1 | 325 |
Si et al. [32] | 0.73 | 0.64-0.82 | 3.36Â ng/ml | 0.63 | 0.46 | 76 | 25 | 45 | 22 |
Wang et al. [25] | 0.81 | 0.71-0.91 | 150Â ng/ml | 0.79 | 0.90 | 26 | 5 | 7 | 49 |
Xing et al. [26] (p) | 0.86 | 0.77-0.94 | 92.5Â ng/ml | 0.85 | 0.87 | 30 | 5 | 5 | 33 |
Xing et al. [26] (u) | 0.93 | 0.88-0.93 | 118.5Â ng/ml | 0.93 | 0.89 | 32 | 4 | 3 | 34 |
Yan et al. [27] | 0.93 | 0.88-0.98 | 65 μg/l | 0.95 | 0.86 | 54 | 8 | 3 | 47 |
Yan and Xang [28] | 0.86 | 0.70-0.96 | 90 μg/l | 0.87 | 0.86 | 38 | 14 | 6 | 83 |
Zhou et al. [35] | 0.80 | 0.7Â l-0.93 | 85Â ng/l | 0.78 | 0.80 | 36 | 20 | 10 | 82 |